Seaport and Hemab target $180m IPOs as biotech listings accumulatePharmaceutical Technology·Apr 28 at 05:22 AM426CVR015TMPCOEP0.00%
Hemostemix Raises $784,000 to Advance Stem Cell Therapy CommercializationTip Ranks·Mar 19 at 09:08 PMIBB+0.22%426CVR015TMP
Hemostemix Leadership Attending Abundance360 Summit | HMTXF Stock NewsStockTitan·Mar 9 at 02:23 AMAMIX-24.07%426CVR015TMP
Psychedelic biotechs are moving towards Phase 3 with five companies advancing CNS treatments for depression and anxiety.Unusual Whales·Feb 27 at 10:46 AMFBT+0.32%SBIO+2.38%
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AMLTip Ranks·Feb 10 at 09:57 AMHEPA-20.69%426CVR015TMP
